Loading...
Loading...
Among the 5 tracked institutional investors we monitor, ANVS (ANNOVIS BIO INC) is held with a combined value of $4.69M across 1,592,969 shares. The largest holder is VANGUARD GROUP INC with a position worth $3.19M (0.00% of their portfolio). 2 funds opened new positions in the most recent quarter. 1 fund increased its holdings. 1 fund reduced its position.
Total Institutional Value
$4.69M
Total Shares Held
1,592,969
Institutional Holders
5
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $3.19M | 0.00% | New |
| 2 | RENAISSANCE TECHNOLOGIES LLC | $775.15K | 0.00% | New |
| 3 | BlackRock, Inc. | $311.16K | 0.00% | - |
| 4 | CITADEL ADVISORS LLC | $233.93K | 0.00% | -49.1% |
| 5 | STATE STREET CORP | $173.35K | 0.00% | +5.0% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of ANVS with a position worth $3.19M, representing 0.00% of their portfolio. In total, 5 institutional investors hold ANVS with a combined value of $4.69M.
In the most recent quarter, 2 funds opened a new position in ANVS. Additionally, 1 increased their holdings and 1 reduced their positions.
Institutional investors hold $4.69M worth of ANVS stock across 5 positions. The largest institutional holder is VANGUARD GROUP INC with $3.19M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ANVS, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their ANVS positions.